Pulmonary Blastoma: A Rare Primary Lung Malignancy
Pulmonary blastoma, a rare primary lung malignancy, is considered to be distinct from other lung tumors based on pathological features, clinical course, and prognosis. More than one hundred cases have been reported in literature highlighting an interesting fact about their distinctive biologic manne...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | Case Reports in Medicine |
Online Access: | http://dx.doi.org/10.1155/2012/471613 |
id |
doaj-28b44046107b4843a821311f1277b436 |
---|---|
record_format |
Article |
spelling |
doaj-28b44046107b4843a821311f1277b4362020-11-24T23:28:38ZengHindawi LimitedCase Reports in Medicine1687-96271687-96352012-01-01201210.1155/2012/471613471613Pulmonary Blastoma: A Rare Primary Lung MalignancyMahmoud S. Alahwal0Iqbal H. Maniyar1Faiza Saleem2Mariam Alshiekh3Medical Oncology, Faculty of Medicine, King Abdulaziz University, Jeddah 22254, Saudi ArabiaMedical Oncology, Faculty of Medicine, King Abdulaziz University, Jeddah 22254, Saudi ArabiaMedical Oncology, Faculty of Medicine, King Abdulaziz University, Jeddah 22254, Saudi ArabiaFaculty of Medicine, King Abdulaziz University, Jeddah 22254, Saudi ArabiaPulmonary blastoma, a rare primary lung malignancy, is considered to be distinct from other lung tumors based on pathological features, clinical course, and prognosis. More than one hundred cases have been reported in literature highlighting an interesting fact about their distinctive biologic manner from histopathological features. Classic pulmonary blastoma is composed of a mixture of immature epithelial and mesenchymal tissue resembling fetal lung tissue. Surgery is the mainstay of treatment. The prognosis of this rare malignancy is poor and the overall 5-year survival is around 15%. Our patient presented with respiratory symptoms and was found to have right-sided chest wall mass. The patient underwent complete surgical excision followed by 6 cycles of platinum-based chemotherapy. The patient showed good subjective and objective response with no evidence of disease recurrence. We report this rare malignancy with a review of literature, and the potential to use adjuvant chemotherapy in the management of this condition.http://dx.doi.org/10.1155/2012/471613 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Mahmoud S. Alahwal Iqbal H. Maniyar Faiza Saleem Mariam Alshiekh |
spellingShingle |
Mahmoud S. Alahwal Iqbal H. Maniyar Faiza Saleem Mariam Alshiekh Pulmonary Blastoma: A Rare Primary Lung Malignancy Case Reports in Medicine |
author_facet |
Mahmoud S. Alahwal Iqbal H. Maniyar Faiza Saleem Mariam Alshiekh |
author_sort |
Mahmoud S. Alahwal |
title |
Pulmonary Blastoma: A Rare Primary Lung Malignancy |
title_short |
Pulmonary Blastoma: A Rare Primary Lung Malignancy |
title_full |
Pulmonary Blastoma: A Rare Primary Lung Malignancy |
title_fullStr |
Pulmonary Blastoma: A Rare Primary Lung Malignancy |
title_full_unstemmed |
Pulmonary Blastoma: A Rare Primary Lung Malignancy |
title_sort |
pulmonary blastoma: a rare primary lung malignancy |
publisher |
Hindawi Limited |
series |
Case Reports in Medicine |
issn |
1687-9627 1687-9635 |
publishDate |
2012-01-01 |
description |
Pulmonary blastoma, a rare primary lung malignancy, is considered to be distinct from other lung tumors based on pathological features, clinical course, and prognosis. More than one hundred cases have been reported in literature highlighting an interesting fact about their distinctive biologic manner from histopathological features. Classic pulmonary blastoma is composed of a mixture of immature epithelial and mesenchymal tissue resembling fetal lung tissue. Surgery is the mainstay of treatment. The prognosis of this rare malignancy is poor and the overall 5-year survival is around 15%. Our patient presented with respiratory symptoms and was found to have right-sided chest wall mass. The patient underwent complete surgical excision followed by 6 cycles of platinum-based chemotherapy. The patient showed good subjective and objective response with no evidence of disease recurrence. We report this rare malignancy with a review of literature, and the potential to use adjuvant chemotherapy in the management of this condition. |
url |
http://dx.doi.org/10.1155/2012/471613 |
work_keys_str_mv |
AT mahmoudsalahwal pulmonaryblastomaarareprimarylungmalignancy AT iqbalhmaniyar pulmonaryblastomaarareprimarylungmalignancy AT faizasaleem pulmonaryblastomaarareprimarylungmalignancy AT mariamalshiekh pulmonaryblastomaarareprimarylungmalignancy |
_version_ |
1725548700140306432 |